[1]
E. . Hu and Y. Qiu, “Prognostic Significance of Circulating Immune-Inflammatory Biomarkers IL-6 and Systemic Immune-Inflammation Index in Hepatocellular Carcinoma Treated With Immune Checkpoint Inhibitors: A Meta-Analysis: Circulating Immune-Inflammatory Biomarkers in HCC”, J Med Biochem, vol. 45, no. 6, pp. 1222–1231, Mar. 2026, doi: 10.5937/jomb0-64710.